DABRA (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) is a novel, minimally invasive excimer laser atherectomy system that non-thermally, photochemically ablates channels in ...
CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, ...
Addition of laser atherectomy provides better short-term results than balloon angioplasty alone in patients with restenosis in peripheral stents. In fact, the randomized, multicenter EXCITE ISR trial ...
Spectranetics To Initiate Landmark Randomized Study Of Laser Treatment For Peripheral Artery Disease
Spectranetics Corporation today announced that it plans to initiate the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial ...
Philips debuts three new solutions in the North American market that will help drive procedural innovation and workflow efficiency, adding to the company’s ecosystem of interventional imaging systems, ...
After nearly two decades developing excimer lasers to treat both dermatological conditions and peripheral artery disease, Ra Medical is now pursuing a “divide and conquer” strategy with the sale of ...
Following a successful initial public offering (IPO) in late September, the stock price of Ra Medical Systems has subsequently slumped in value by 40 per cent. The Californian company, which recently ...
Spectranetics to Initiate Landmark Randomized Study of Laser Treatment for Peripheral Artery Disease
Excimer laser procedure to be tested on more than 350 patients. COLORADO SPRINGS, Colo.--(BUSINESS WIRE)-- Spectranetics Corporation (Nasdaq:SPNC - News) today announced that it plans to initiate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback